2015 Pediatric RX, Module 5: Identification and Treatment of Common Ingestions in Adolescents and Young Adults

Introduction

An extensive review will provide an up-to-date information on symptoms of and treatment for overdose or toxicity of common ingestions.

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.75 NAPNAP contact hours, of which 0.75 is pharmacology content.

IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org

Copyright 2015 © by National Association of Pediatric Nurse Practitioners (NAPNAP)

Target Audience

Pediatric-focused advanced practice registered nurses

Learning Objectives

  1. Review current patterns of illicit and licit substance use and abuse among adolescents and young adults.
  2. Discuss common substances adolescents and college students are ingesting and using to become intoxicated.
  3. Review symptoms of and treatment for overdose or toxicity of common ingestions.
Course summary
Available credit: 
  • 0.75 Contact hours
Course opens: 
10/01/2015
Course expires: 
09/30/2017
Cost:
$10.00

Teri Moser Woo, PhD, CPNP, CNL, FAANP, Associate Dean for Graduate Nursing Programs, Pacific Lutheran University, Tacoma, Wash.; Woodcreek Pediatrics, Puyallup, Wash.

FACULTY DISCLOSURES 

Dr. Moser Woo has no financial relationships with any commercial entities to disclose, and will not discuss off label use and/or investigational use of individual drugs in this presentation.

Available Credit

  • 0.75 Contact hours

Price

Cost:
$10.00
Please login or register to take this course.